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EDITORIAL

Myocardial Perfusion Imaging: The Gatekeeper and Advisor
Maseeh uz Zaman and Nosheen Fatima

Radiation-based morphological and functional imagings,
like radiology and nuclear medicine, are considered the
standard of care in modern medicine. Nuclear cardiology
is one of the most important domains of nuclear
medicine which has been playing an important role in the
diagnosis, prognosis, and decision-making in clinical
cardiology. Myocardial perfusion imagings (MPIs), using
single-photon emission computerised tomography
(SPECT) and positron emission tomography (PET), are
the most commonly performed nuclear cardiology
procedures worldwide. Reasons for MPI's unprecedented
popularity are its ability to study myocardial perfusion
non-invasively, precise estimation of left ventricular
function, myocardial viability and risk stratification in
patients with known coronary artery disease (CAD) or
after myocardial infarction. Multigated acquisition
(MUGA) imaging is considered as the modality of choice
for precise assessment of left ventricular ejection
fraction (LVEF) and volumes. But echocardiogram, being
the major competitor, is leading far ahead in the clinical
practice. Similarly, radionuclide first passed radionuclide
angiogram (FPRA) is considered as the gold standard
for precise estimation of right ventricular ejection fraction
(RVEF) and cardiac shunt quantification, but could not
get popularity.

Over the last four decades, MPI has become a major
non-invasive tool for evaluation of CAD.1 However, the
greatest strength of MPI is due to its established role in
risk stratification in patients with known CAD or postmyocardial infarction.2 Precise assessment of
myocardial blood flow (MBF), using PET or SPECT
methodology, has made MPI an indispensable tool for
evaluation and management of CAD.3 The most popular
indication of MPI is its role as the gatekeeper to
catheterisation laboratory for selection of the patients
who need invasive approach or would require
conservative management. Other important indications
of MPI are the diagnosis of CAD in patients with
intermediate pretest probability or asymptomatic
patients with abnormal ECG or symptomatic patient with
normal ECG. MPI is also indicated for assessment of
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efficacy of therapeutic interventions like angioplasty or
coronary artery bypass graft (CABG) surgery, risk
stratification, and preoperative cardiac assessment in
intermediate to high risk patients. Quantification of
coronary flow reserve (CFR), using PET or SPECT,
provides an important piece of clinical information about
the hemodynamic significance of epicardial coronary
lesion or diagnosis of small vessel disease.1 Recently,
plaque imaging using PET-MPI has opened new avenue
for detection of vulnerable plaques, and targeted therapy
of these plaque is expected to reduce CAD related
morbidity and mortality.4

Radiopharmaceuticals, which are used for MPI, include
Tc-99m labelled Methoxy IsoButyl Isonitrile (MIBI),
Tetrofosmin (MYOVIEW), BATO and NOET compounds.
Last two agents have not yet approved for clinical use so
far. For assessment of the myocardial viability, Thallium201 (Tl-201) is more sensitive and specific, as presence
of redistribution is a reliable indicator of intact cell
membrane and cell viability. However, due to its cost and
significantly higher radiation exposure, various centres
use Tc-99m MIBI and MYOVIEW with sublingual nitrate
augmentation with reasonably good diagnostic accuracy.5
MPI is performed to assess the LV myocardial perfusion
and function during stress and at rest. For stress part,
dynamic exercise on treadmill or ergometer using Bruce
or Modified Bruce protocol is a preferred choice as it is
more physiological and provides important information
about the functional capacity like Metabolic Equivalent
(METS), which has an established prognostic value for
future cardiac events. For patients who are unable to
perform exercise due to physical limitation or unreadable
ECGs like left bundle branch block (LBBB) or WolffeParkinson-White (WPW) syndrome, vasodilator infusion
like adenosine, dipyridamole or regadenoson are the
alternatives. However, these are not indicated if patient
has history of bronchospasm or asthma as these agents
may induce severe bronchospasm (less likely with
regadenoson). Vasodilator stress may be used with low
level exercise (hybrid protocol) as this modification
reduces the side effects like headache and hypotension;
and also increases the sensitivity of test as well. Tc-99m
MIBI or MYOVIEW are injected intravenously at peak
stress and during resting status as these agents
distribute according to regional perfusion status at the
time of injection and gets fixed into myocardium and
provides a snap-shot images of LV perfusion later on.
Stress and rest MPIs may be performed on two separate
days (average 1.5 hour/day) or the same day (average
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3-4 hours). Gated SPECT images are acquired under a
gamma camera, which needs 15-20 minutes for
acquisition of complete set of data. After reconstruction,
images are analysed visually and semi-quantitatively
using 17 segment model of American Heart Association
(AHA) for assessment of LV perfusion, function, wall
motion abnormality and thickness.6

Based on MPI findings, patients are categorised as low
(<1%), intermediate (1-3%), and high (>3%) risk groups
for probability of annual major acute cardiac events
(MACE) like fatal or non-fatal myocardial infarction. A
normal Gated MPI (GMPI) has a negative predictive
value (NPV) of >99% with an established 0.4-0.6%
annual incidence of MACE for exercise GMPI. However,
NPV of vasodilator stress GMPI is relatively low as
compared to exercise GMPI.7 Various management
strategies have been formulated based on perfusion and
functional parameters like LVEF and end systolic volume
(ESV) derived from GMPI. Patients with LVEF >50%,
without or with mild to moderate perfusion defects,
are considered low risk and deserve conservative
management; but those with LVEF 30-50% with mild to
moderate perfusion defects are considered intermediate
risk and are considered candidates for revascularisation.
Patients with LVEF <30% are considered at high risk and
subjected to viability study with Thallium-201 or MIBI or
MYOVIEW with nitrate augmentation to confirm
presence of hibernating myocardium. Presence or
absence of hibernating myocardium guides the treating
cardiologist about revascularisation or conservative
management, respectively. Similarly, patients with LVEF
<45% and ESV <70 ml or LVEF < 45% and ESV >70 ml
are considered to have lower and higher annual
mortality rates, respectively.8
In recent years PET/CT has also stepped in from oncology
into clinical cardiology domain. Being a hybrid imaging
modality, it provides information regarding perfusion,
function, coronary artery calcium (CAC), coronary
anatomy, and precise estimation of CFR in one session.
This one-stop-shop solution with lesser time and lesser
radiation exposure are the real driving forces favouring
the robust growth of PET/CT MPI. However, availability
of PET/CT facilities and its cost are the major
antagonistic factors.9
Over the last four decades, there has been a tremendous
increase in utilisation of SPECT-MPI all over the world.
High sensitivity, non-invasiveness, and relatively easy
availability are the major factors responsible for this
positive worldwide trend. However, this trend has also
contributed significantly high radiation exposure to
general public. According to a report, radiation exposure
from SPECT-MPI has increased from 1% to 10.5% of
total exposure over the last 35 years to US population.
Similarly, according to National Council for Radiation
Protection and Management (NCRP), over the last 30
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years there has been six-fold increase in radiation
exposure to the American population.10 Stochastic
effects of radiation, like malignancy or genetic mutations,
are the primary concerns which are unfortunately less
understood by medical community. To address these
issues, International Atomic Energy Agency (IAEA) has
introduced strategy of justification and optimisation for
radiation-based procedures. Similarly, American Society
of Nuclear Cardiology (ASNC) has introduced appropriate
use criteria (AUC) for MPI in an attempt to curtail
unjustified MPIs contributing to radiation exposure to
general public. Various professional societies of US and
Europe have also released radiation dose reducing
guidelines like use of stress-only protocol, use of low
doses of radioisotope, use of more sensitive gamma
cameras, use of better reconstructive algorithm and
preference of PET-MPI over SPECT-MPI, when
available.1

MPI using SPECT or PET is the most sensitive
functional imaging modality for precise assessment of
myocardial perfusion and function. Being a non-invasive
tool, it guides the cardiologists about the presence of
functionally significant CAD, selection of appropriate
treatment strategies, and most importantly risk
stratification in patients with or without a major cardiac
event. SPECT-MPI has been used overwhelmingly
worldwide in the last four decades, which has made it
one of the major contributors of radiation exposure to
general public. Stochastic effects, like cancer and genetic
mutations, are the major concerns which are
unfortunately less understood. To address this important
aspect, various strategies have been formulated by
IAEA; and various appropriate use criteria have been
released by professional societies of the US and
Europe. Recently, PET-MPI has been promoted over
SPECT-MPI due to its higher sensitivity, diagnostic
accuracy, and absolute quantification of various
functional parameters in shorter time with significantly
lower radiation exposures.
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